iZumi Bio Inc., a South San Francisco-based regenerative medicine company that uses induced pluripotent stem (iPS) cells, has raised $20 million in VC funding since its 2007 inception. Backers include Highland Capital Partners and Kleiner Perkins Caufield & Byers.

 

The funding amount was disclosed in a USA Today article, about how the company has forged a partnership with Kyoto University‘s Shinya Yamanaka. www.izumibio.com

Related posts:

  1. PayMate Raises $9 Million
  2. RazorGator Raises $7.5 Million
  3. OptiMedica Raises $16 Million
  4. Codon Devices Raises $20 Million
  5. Stoke Raises $20 Million